Tag: Coronavirus

How the CRUK Manchester Institute at the University of Manchester are...

EACR President Elect Caroline Dive writes about her institute's work towards the United Kingdom's efforts with testing for SARS-CoV-2. As COVID-19 disease in the UK...

The Two Challenges to our New Normal

The cancer research community is reacting and adapting to the restrictions placed on us by the COVID-19 outbreak. We’ve asked EACR members to contribute articles...

WATCH NOW: Alberto Bardelli on ‘Inactivation of DNA repair and high...

The EACR is launching a programme of virtual events to bring researchers together. We'd like to thank all of the EACR Ambassadors who volunteered...

Research on hold? Seek new shores and revisit old ones

The cancer research community is reacting and adapting to the restrictions placed on us by the COVID-19 outbreak. We’ve asked EACR members to contribute articles...

A week in the life of a locked-down cancer researcher

A while ago, back when I was still a PhD student and over here in the UK, Brexit dominated the news (and in hindsight...

Lockdown: A Cancer Researcher’s Guide

The cancer research community is reacting and adapting to the restrictions placed on us by the COVID-19 outbreak. We’ve asked EACR members to contribute articles...

When it’s Challenging, Think Outside of the Box

The cancer research community is reacting and adapting to the restrictions placed on us by the COVID-19 outbreak. We’ve asked EACR members to contribute...

Call for articles: How to be a cancer researcher in the...

Share your ideas and experiences in the EACR’s online magazine, The Cancer Researcher With many parts of the world on lockdown and/or working from home...

Who are we?

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research (EACR).

Sign up for the EACR's email newsletter for cancer researchers, usually sent every 2 weeks.

Advertisement
Advertisement
Advertisement

More articles

Lessons from Precision Oncology

by Mark A. Rubin1,2 1 Department for BioMedical Research, University of Bern, Bern, Switzerland, 2 Weill Cornell Medical Collage, New York, USA Name and circumstances...